Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor agents from Daiichi

April 1, 1997

Evanston Hospital discloses radio- and chemosensitizers

March 27, 1997

Aphton issued U.S. patents covering Gastrimmune

March 26, 1997

Kitasato Institute discovers inhibitor of IL-6 activity

March 26, 1997

Taiho discloses antiangiogenic agents

March 26, 1997

Geron and Pharmacia & Upjohn collaborate on telomerase inhibitors

March 25, 1997

Sparta's i.v. formulation of busulfan enters phase I

March 25, 1997

Tokyo University researchers characterize new steroidal saponin

March 25, 1997

Daiichi discloses new antitumor agents

March 25, 1997

Preliminary phase I results for annamycin

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...